Healthtech Startups

StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.

1 investor

STENTiT is a Dutch medtech company developing the Resorbable Fibrillated Scaffold (RFS), a device designed to trigger natural healing and reconstruct arteries for treating vascular conditions. The technology initially targets below-the-knee chronic limb threatening ischemia and has broader applications across endovascular treatments.

1 investor

Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation. Its technology serves physicians and hospitals performing minimally invasive interventional treatments.

1 investor

Sterilex develops sanitation, disinfection, and microbial control products for use in food processing facilities, water systems, and animal environments.

1 investor

Stethy offers a platform with pre-built, validated AI workflow templates that healthcare and life-science organizations deploy without code to automate clinical processes such as documentation, pharmacovigilance, and compliance checks. Its models are fine-tuned for life-science data and include safety guardrails and proprietary adverse event detection to meet regulatory standards.

1 investor

Stiefel is a biopharmaceutical company that discovers, develops and delivers medicines and vaccines. Its R&D focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

1 investor

StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.

1 investor

StimLabs develops regenerative medicine products, including its Corplex P device, used by physicians for wound healing and complex clinical cases. The company markets a portfolio of regenerative technologies for patient care.

1 investor

StimuSIL is a medical device company developing subdermal photobiomodulation technology that uses patented methods to deliver light-based stimulation beneath the skin's melanin layer for dermatology and aesthetics indications. Its lead preclinical candidate targets androgenetic alopecia (hair loss), with a research pipeline covering vitiligo, psoriasis, wrinkles, cellulite, and acne scars.

1 investor

1 investor

Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.

1 investor

Stitch is a care coordination platform that enables healthcare teams to communicate through messaging, file sharing, and real-time collaboration across devices. It provides alternatives to traditional communication methods like pagers and email for clinical settings.

1 investor

STM develops microneedle patch technology for painless, temperature-stable delivery of drugs, vaccines, and supplements to humans, animals, and for nutraceutical applications. The platform eliminates cold-chain storage requirements and enables single-application multi-dose delivery across therapeutic and preventative use cases.

1 investor

StockRx provides inventory management software for independent pharmacies and pharmacy groups, digitising the goods-in process and tracking deliveries, supplier performance, and dispensary profitability in real time. Its features include margin analysis, automated credit note and claims management, invoice-to-statement reconciliation, and compliance reporting.

1 investor

Storbie provides an integrated retail and engagement platform that helps community pharmacies and veterinary practices build an online presence, connecting them with industry groups and suppliers. The platform supports showcasing products and services, managing appointments, and promotion, with a stated focus on small businesses in New Zealand, Australia, and the United States.

1 investor

STRAFFR makes a smart resistance fitness band paired with a mobile app that guides and tracks strength workouts for home and travel exercisers. The German consumer fitness product is used by several thousand people across more than 30 countries.

1 investor

Strand AI predicts missing biological data modalities from existing patient data, converting single histopathology slides into spatial protein maps and inferring gene expression from genotype. The platform serves researchers and clinicians in computational pathology and genomics.

1 investor

Strata Skin Sciences develops and provides dermatology treatment devices, including the XTRAC excimer laser and VTRAC excimer lamp for psoriasis and vitiligo, and the TheraClearX photopneumatic system for acne. Its products serve professionals in dermatology, plastic surgery, and aesthetics.

1 investor

Strata offers a platform that combines EMR, billing, and revenue cycle management into a single system, using proprietary AI to identify claim errors and prevent denials before submission. It serves medical practices of all sizes, from startups to large enterprises, to help them manage operations and collect payments.

1 investor

Stratosvir develops engineered viral immunotherapy treatments for advanced cancers, including prostate cancer, using modified viruses to activate the body's immune system against tumors. The company targets patients with advanced solid tumors where current treatment options are limited.

1 investor

Stratus builds an AI platform for dental practice front desks, automating insurance verification and coordination so staff spend minutes rather than hours on claims and calls. It serves dental offices and office managers, with plans to expand into claims, scheduling, and other practice management tasks.

1 investor

Stratus Medical manufactures radiofrequency technology-based medical devices for chronic pain management, with a primary product called NIMBUS that provides sustained pain relief through large-volume lesioning. The company sells directly in the United States and through distributors in Australia, Brazil, Italy, Portugal, Spain, United Kingdom, United Arab Emirates, and other markets.

1 investor

Stratus Neuro provides EEG hardware products and clinical software solutions for hospital systems and neurology practices. The company distributes electroencephalography equipment including mobile cart systems, point-of-care nets, and ambulatory EEG kits for inpatient and outpatient neurodiagnostics.

1 investor

Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems. Its lead program targets Alzheimer's disease and related dementias, with potential use in stroke, traumatic brain injury, and other neurological conditions.

1 investor